SCHEMBL4968877

SCHEMBL4968877

COc1cc2c(c(-c3ccc(F)c(Cl)c3)c1)OC(CNc1ccccc1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.42
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
FABP4 P15090 2/20 0.35
FABP5 Q01469 2/20 0.35
EZH2 Q15910 1/20 0.35
PRKAB2 O43741 2/20 0.35
PRKAG1 P54619 2/20 0.35
PRKAA2 P54646 2/20 0.35
PRKAA1 Q13131 2/20 0.35
PRKAG3 Q9UGI9 2/20 0.35
PRKAG2 Q9UGJ0 2/20 0.35
PRKAB1 Q9Y478 2/20 0.35
ACP1 P24666 1/20 0.35
FABP3 P05413 1/20 0.35
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4220623 0.87 AQP1 (0.54) AQP1MEN1MAPTKMT2AEZH2
SCHEMBL5140813 0.84 AQP1 (0.43) AQP1NFKB1NFKB2RELAMEN1
SCHEMBL4225394 0.83 AQP1 (0.51) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL4220627 0.82 AQP1 (0.43) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL4834018 0.79 NFKB1 (0.42) AQP1NFKB1NFKB2RELAMEN1
SCHEMBL5058630 0.78 GRM2 (0.38) MAPTPTGS2
SCHEMBL4968974 0.78 AQP1 (0.54) AQP1NFKB1NFKB2RELAMEN1
SCHEMBL5058627 0.78 PTGS2 (0.36) AQP1MAPTPTGS2
SCHEMBL4867031 0.75 AQP1 (0.60) AQP1EZH2PRKAB2PRKAG1PRKAA2
SCHEMBL4222333 0.75 PTGS2 (0.38) AQP1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898895-A2 TREATMENT OF DRUG ABUSE Wyeth (US) 2008-03-19 EP claimed
WO-2006116148-A2 (7-ARLYSUBSTITUTED 2, 3-DIHYDR0-1-BENZ0FURAN-2-YL) ALKYLAMINES IN THE TREATMENT' OF SUBSTANCE ABUSE WYETH (US) 2006-11-02 WO claimed